This preview shows page 1. Sign up to view the full content.
Unformatted text preview: rological diseases, cancer, and AIDS. While it was often the clinical trial itself that gave rise to a question that required new methodology to answer, it is likely that the methods will nd applications in other medical elds. In this sense, the contributions are examples of ideal biostatistics, tran-scending the boundary between statistical theory and clinical trials prac-tice. I wish to express my deep appreciation to all the authors for their patience and collegiality and for their ne contributions and outstanding expositions. I also thank my husband for his constant encouragement and Marcel Dekker, Inc., for their continuing interest in this project. Nancy L. Geller Copyright n 2004 by Marcel Dekker, Inc. All Rights Reserved....
View Full Document
- Spring '11